Rievent · Enduring Material
Adjuvant Therapy in Recurrent High-Risk Cutaneous Squamous Cell Carcinoma: Advancing Multidisciplinary Decision-Making
This CME/CE activity reviews best practices for managing patients with recurrent high-risk cSCC who are receiving adjuvant therapy in a coordinated, multidisciplinary manner.